PRO Consortium Workshop 2017: Difference between revisions

From NCOR Wiki
Jump to navigationJump to search
mNo edit summary
Line 19: Line 19:
: - how proteomic information in general and the PRO in particular can help us to understand the relationship between genotype and phenotype, for example in understanding disease etiology
: - how proteomic information in general and the PRO in particular can help us to understand the relationship between genotype and phenotype, for example in understanding disease etiology
: - which [http://obofoundry.org/ro/ relations] we should use in linking the protein entities represented in the PRO to disease entities
: - which [http://obofoundry.org/ro/ relations] we should use in linking the protein entities represented in the PRO to disease entities
: - which are the important entities on the protein side that need to be linked
: - which are the important entities on the protein side that need to be linked -- focus on PTMs, sites


*Relating to PRO's interactions with external resources:
*Relating to PRO's interactions with external resources:
:'''UniProt''': Draft of policies/recommendations regarding accession/site tracking for UniProt and PRO
:'''UniProt''': Draft of policies/recommendations regarding accession/site tracking for UniProt and PRO
:'''IntAct''': Identify points of agreement and discrepancy in curation pipelines and resolve as appropriate. Reach agreements for example on reciprocal links and accession issues
The future development of PRO and of PRO’s role in the Alliance of Genome Resources
Use of Noctua for GO annotation, use of PRO in Noctua


Benefits and limitations of PRO
Benefits and limitations of PRO
Line 43: Line 36:
=='''Schedule: Wednesday, October, 11, 2017==
=='''Schedule: Wednesday, October, 11, 2017==


<u>Chair: TBD</u> '''PRO and Disease'''
<u>Chair: TBD</u> '''The future of the PRO'''
 
Sites
PTMs
 
 
8:45 Cathy Wu: Protein Ontology: Its current state and future development


8:45 Cathy Wu: The current state of the Protein Ontology
TBD: ProKinO: Protein Kinase Ontology Browser


Judith Blake (MGI): Disease Ontology -- overview of available resources
TBD: NeXtProt


Melissa Chessler (MGI): MGI effort to combine variant data with disease forms
Pamela VanAuken: Noctua


Barry Smith Protein-Disease Relations
Cindy Smith: The Alliance of Genome Resources


10:30 Break
10:30 Break


10:45
10:45 '''PRO and software / NLP / SPARQL'''
 
ChuMing: Writing SPARQL queries for PRO
 
PRO and its relations to the experimental community
 
Chair: Alan Ruttenberg


12:30 Lunch
12:30 Lunch


<u>Chair: Cecilia Arrighi</u>
13:30


13:30
'''PRO and Disease'''
 
Chair: Barry Smith
 
Judith Blake (MGI): Disease Ontology -- overview of available resources
 
Elissa Chesler (MGI): MGI effort to combine variant data with disease forms; Genereader resource, PRO IDs for variants
 
Barry Smith Protein-Disease Relations
 
Other large-scale frameworks working with protein variants


14:30 Break
14:30 Break
Line 75: Line 90:
8:00 Continental breakfast
8:00 Continental breakfast


<u>Chair: TBD</u> '''GO, PRO and UniProt: How they should work together'''
'''GO, PRO and UniProt: How they should work together'''
 
Chair: TBD


9:00 Alex Bateman (EBI)
9:00 Alex Bateman (EBI)
Line 85: Line 102:
12:00 Lunch
12:00 Lunch


<u>Chair: TBD</u>: PRO and OBO Foundry
12:45 '''PRO and OBO Foundry
 
Chair: TBD
 
Scope of PRO


12:45
Treatment of protein complexes


Alan Ruttenberg: How genes are referenced in OBO Foundry? in PRO?
Alan Ruttenberg: How genes are referenced in OBO Foundry? in PRO?
Line 93: Line 114:
Participants: Chris Mungall, Darren Natale
Participants: Chris Mungall, Darren Natale


14:00 Close of Plenary Sessions.
Proper treatment of functions in PRO
 
14:00 Close of Plenary Sessions
 
 


14:00 Working group meetings
14:00 Working group meetings

Revision as of 18:30, 18 May 2017

Date: October 11-12, 2017

Venue: Jackson Lab, Bar Habor, Maine


Goals and outcomes

The goals of this meeting are:

  • 1. To contribute to the ontological understanding of phenotype and disease across organisms
  • 2. To advance the treatment of protein-related clinical and translational data from the perspective of consistency, discoverability and support for diagnosis
  • 3. To advance coordination between the Protein Ontology and other protein-related information resources

Desired outcomes are of two sorts:

  • Relating to disease:
We will seek greater clarity as to
- how proteomic information in general and the PRO in particular can help us to understand the relationship between genotype and phenotype, for example in understanding disease etiology
- which relations we should use in linking the protein entities represented in the PRO to disease entities
- which are the important entities on the protein side that need to be linked -- focus on PTMs, sites
  • Relating to PRO's interactions with external resources:
UniProt: Draft of policies/recommendations regarding accession/site tracking for UniProt and PRO

Benefits and limitations of PRO

PRO and PTM knowledge networks

Developing PROs scope for annotating diseases

Schedule: Tuesday, October, 10, 2017

19:00 Informal reception for early arrivals in conference hotel

Schedule: Wednesday, October, 11, 2017

Chair: TBD The future of the PRO

Sites PTMs


8:45 Cathy Wu: Protein Ontology: Its current state and future development

TBD: ProKinO: Protein Kinase Ontology Browser

TBD: NeXtProt

Pamela VanAuken: Noctua

Cindy Smith: The Alliance of Genome Resources

10:30 Break

10:45 PRO and software / NLP / SPARQL

ChuMing: Writing SPARQL queries for PRO

PRO and its relations to the experimental community

Chair: Alan Ruttenberg

12:30 Lunch

13:30

PRO and Disease

Chair: Barry Smith

Judith Blake (MGI): Disease Ontology -- overview of available resources

Elissa Chesler (MGI): MGI effort to combine variant data with disease forms; Genereader resource, PRO IDs for variants

Barry Smith Protein-Disease Relations

Other large-scale frameworks working with protein variants

14:30 Break

14:45

16:00 Close

Schedule: Thursday, October 12, 2017

Venue: JAX

8:00 Continental breakfast

GO, PRO and UniProt: How they should work together

Chair: TBD

9:00 Alex Bateman (EBI)

10:30 Break

10:45

12:00 Lunch

12:45 PRO and OBO Foundry

Chair: TBD

Scope of PRO

Treatment of protein complexes

Alan Ruttenberg: How genes are referenced in OBO Foundry? in PRO?

Participants: Chris Mungall, Darren Natale

Proper treatment of functions in PRO

14:00 Close of Plenary Sessions


14:00 Working group meetings

17:00 Close


Participants

Cecilia Arighi (Delaware / PRO)
Erich Baker (Baylor))
Alex Bateman (EBI)
Judith Blake (JAX)
Elissa Chesler (JAX)
? Karen Christie (JAX)
Alex Diehl (Buffalo)
Harold Drabkin (JAX)
? Gang Fu (NCBI / NIH)
? John S. Garavelli (Delaware)
? Donna Maglott (NIH / NLM / NCBI)
Darren Natale (Georgetown)
? Veerasamy “Ravi” Ravichandran (NIH / NIGMS)
? Karen Ross (Delaware)
Alan Ruttenberg (Buffalo)
Cynthia Smith (JAX)
Barry Smith (Buffalo)
Kimberley VanAuken (CalTech)
Laurens Wilming (JAX)
Cathy Wu (Delaware / PRO)

Please contact Barry Smith for further information.

Sponsors

The Protein Ontology Consortium
National Center for Ontological Research